• T Perez, H Mal, B Aguilaniu, P-Y Brillet, A Chaouat, R Louis, J-F Muir, T Similowski, P Berger, P-R Burgel, A Chambellan, P Chanez, P Devillier, R Escamilla, R Marthan, B Wallaert, M Aubier, and N Roche.
• Service de pneumologie et immuno-allergologie, hôpital Calmette, CHRU de Lille, boulevard du Professeur-J.-Leclercq, Lille, France. thierry.perez@chru-lille.fr
• Rev Mal Respir. 2011 Feb 1;28(2):192-215.

IntroductionThe objective of the present article is to review available data on possible links between phenotypes and inflammatory profiles in patients with chronic obstructive pulmonary disease (COPD).BackgroundChronic bronchitis is associated with proximal bronchial inflammation and small airway inflammation with remodeling at the site of obstruction. CT scanning enables patients to be phenotyped according to the predominantly bronchial or emphysematous nature of the morphological abnormality. Exacerbations, in a context of persistently elevated baseline inflammation, are associated with increased inflammation and a poor prognosis. Long-term studies have correlated inflammatory markers (and anti-inflammatory drug effects) with dynamic hyperinflation, possibly confirming that inflammation promotes hyperinflation. The inflammatory cell count in the pulmonary arterial walls correlates with the severity of endothelial dysfunction. The risk of developing pulmonary hypertension would seem to increase with low-grade systemic inflammation. The role of low-grade systemic inflammation in COPD co-morbidities, and in nutritional and muscular involvement in particular, remains a matter of debate. Regular physical exercise may help reduce this inflammation.ConclusionsIn COPD, many aspects of the clinical phenotype are related to inflammation. Better knowledge of these relationships could help optimize current and future treatments.Copyright © 2011. Published by Elsevier Masson SAS.

23 keywords...

hide…